Volume 10, supplement issue 3, November 2012
7th European Workshop on Immune-Mediated Inflammatory Diseases
- Issue editors
84 articles in this issue
-
-
-
-
-
-
-
Type 1 regulatory T (Tr1) cells: from the bench to the bedside
Authors (first, second and last of 4)
-
What does it take to be healthy? Investigating immune-deficiency in non-immunodeficient scenarios
Authors (first, second and last of 8)
-
-
-
-
-
-
-
-
-
NF-kappaB inducing kinase (NIK) is a key regulator of inflammation-induced angiogenesis
Authors (first, second and last of 5)
-
Graft versus host disease in humanized mice is differentially controlled by CD28 and CD80/86 antagonists
Authors (first, second and last of 4)
-
-
No lack of regulatory B cells in patients with Multiple Sclerosis
Authors (first, second and last of 14)
-
The role of Bob1 in rheumatoid arthritis: potential implications for autoimmunity
Authors (first, second and last of 8)
-
-
Factor Xa and thrombin induce epithelial-mesenchymal transition by retinal pigment epithelial cells via PDGF-Rβ signaling
Authors (first, second and last of 7)
-
FcRn mediated IgG transport by retinal pigment epithelium cells
Authors (first, second and last of 7)
-
Interaction with activated monocytes enhances cytokine expression and suppressive activity of human CD4+CD45RO+CD25+CD127low regulatory T cells
Authors (first, second and last of 7)
-
Human circulating basophils lack the features of professional antigen presenting cells
Authors (first, second and last of 6)
-
Decreased AIRE and promiscuous gene expression in thymus from Down syndrome individuals may explain predisposition to autoimmunity
Authors (first, second and last of 5)
-
Differential regulation of motility and immune synapses by CD28/ CTLA-4 costimulation in effector and regulatory T cells
Authors (first, second and last of 5)
-
Constitutive MHC class I molecules negatively regulate TLR-triggered inflammatory responses via the Fps–SHP-2 pathway
Authors (first, second and last of 6)
-
-
Dynamics of CXC group chemokine platelet factor 4 (PF4) plasma levels in non-small cell lung cancer (NSCLC)
Authors (first, second and last of 8)
-
Basophil Activation Test in the prediction of anaphylactic reactions against Hymenoptera venom in patients suffering from Systemic Mastocytosis
Authors (first, second and last of 5)
-
-
-
Peripheral blood leukocytes express differential chemokine receptor profiles in irritable bowel syndrome, Crohn’s disease and ulcerative colitis
Authors (first, second and last of 5)
-
IL-17 as an important effector cytokine in a mouse model for S.typhimurium sepsis
Authors (first, second and last of 4)
-
-
Mesenchymal stem cells repress Th17 molecular program through the PD-1 pathway
Authors (first, second and last of 6)
-
Antagonist properties of monoclonal antibodies to human CD28: role of valency and heavy-chain constant domain
Authors (first, second and last of 7)
-
-
SOCS2 expression in bone marrow derived dendritic cells is a positive regulator of T cell activation
Authors (first, second and last of 6)
-
Altered innate functions of myeloid dendritic cells in ANCA-associated vasculitis
Authors (first, second and last of 5)
-
Vascular endothelial growth factor genetic polymorphisms and susceptibility to age-related macular degeneration in Tunisian population
Authors (first, second and last of 12)
-
Macrophage-fibroblast interplay: a target for neuropeptide-based treatment of fibrotic disease?
Authors (first, second and last of 5)
-
PIM2 induced MMP-9 expression in macrophages requires PI3K and Notch1 signaling
Authors (first, second and last of 5)
-
Influence of activating Fcgamma receptors on osteoclast differentiation and bone metabolism
Authors (first, second and last of 5)
-
Deficiency of regulatory B cells in a house dust mite model of asthma
Authors (first, second and last of 8)
-
-
Tolerogenic dendritic cells in experimental autoimmune encephalomyelitis, specific tolerance induction?
Authors (first, second and last of 5)
-
The reason to stop infliximab is clearly related to the existence of new alternatives: a correspondence analysis of biologics, reasons to stop, and time periods
Authors (first, second and last of 4)
